Source comparison
BPC-157 for Post-Illness Immune Recovery: Full Comparison
The table below compares BPC-157 to standard immune recovery approaches used post-illness, focusing on mechanism, timeline to effect, and practical limitations. BPC-157 (250–500mcg/day SC) Stabilises NOS pathways, downregulates NF-κB, enhances angiogenesis 10–
This comparison does not assign a generated winner or score.
- The table below compares BPC-157 to standard immune recovery approaches used post-illness, focusing on mechanism, timeline to effect, and practical limitations.
- BPC-157 (250–500mcg/day SC)
- Stabilises NOS pathways, downregulates NF-κB, enhances angiogenesis
- 10–14 days for fatigue reduction; 21–28 days for mucosal repair
- Requires reconstitution sterility; not FDA-approved; limited human trial data
- Most mechanistically targeted option for cytokine-driven post-viral fatigue and gut barrier dysfunction
- Vitamin C (1000mg+ daily)
- Antioxidant; supports neutrophil function during acute infection
- Minimal effect post-illness unless deficiency present
- Does not modulate inflammatory pathways; primarily prophylactic
- Useful during active infection; negligible impact on protracted recovery phase
- Zinc (40–50mg daily)
- Cofactor for immune cell replication; inhibits viral replication
- Effective during acute phase; no post-illness benefit beyond correcting deficiency
- Excess zinc (>50mg/day long-term) impairs copper absorption
- Relevant only if baseline zinc status is suboptimal
- Probiotics (multi-strain, 10+ billion CFU)
- Restores gut microbiome diversity; reduces intestinal permeability
- 4–8 weeks for gut barrier improvements
- Strain-specific effects; does not address systemic cytokine dysregulation
- Useful adjunct for gut-mediated immune dysfunction; limited impact on non-GI symptoms
- NAC (N-acetylcysteine, 600mg 2x/day)
- Precursor to glutathione; reduces oxidative stress
- 7–14 days for respiratory symptom relief
- Does not modulate angiogenesis or tissue perfusion
- Best for respiratory recovery; less effective for systemic fatigue or muscle weakness
- BPC-157 stands apart because it addresses the vascular and inflammatory dysfunction that persists after pathogen clearance. The phase where most supplements lose relevance. If post-illness symptoms centre on fatigue, muscle weakness, or gut dysfunction, BPC-157 for post-illness immune recovery targets the underlying pathophysiology more directly than conventional immune support.